Literature DB >> 15076180

The challenge of more robust and reproducible methodology in screening for primary aldosteronism.

Richard D Gordon.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15076180     DOI： 10.1097/00004872-200402000-00006

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  6 in total

1.  Laboratory investigation of primary aldosteronism.

Authors:  Michael Stowasser; Paul J Taylor; Eduardo Pimenta; Ashraf H Al-Asaly Ahmed; Richard D Gordon
Journal:  Clin Biochem Rev       Date:  2010-05

2.  A patient with concurrent primary aldosteronism and Page kidney.

Authors:  Chin-Chi Kuo; Huan-Lun Hsu; Chao-Yuan Huang; Kao-Lang Liu; Vin-Cent Wu; Ching-Wei Tsai; Wei-Jie Wang
Journal:  Endocrine       Date:  2010-06-24       Impact factor: 3.633

3.  [Primary hyperaldosteronism: should we pose its systematic detection at health centres?].

Authors:  C Maciá-Bobes; A Ronzón-Fernández; G Castaño-Fernández; P Botas-Cervero
Journal:  Aten Primaria       Date:  2006-02-15       Impact factor: 1.137

Review 4.  Screening for adrenal-endocrine hypertension: overview of accuracy and cost-effectiveness.

Authors:  Gary L Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

5.  The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses.

Authors:  M Tzanela; G Effraimidis; G Effremidis; D Vassiliadi; A Szabo; N Gavalas; A Valatsou; E Botoula; N C Thalassinos
Journal:  Endocrine       Date:  2007-11-27       Impact factor: 3.633

6.  Method development and validation of liquid chromatography-tandem/mass spectrometry for aldosterone in human plasma: Application to drug interaction study of atorvastatin and olmesartan combination.

Authors:  Rakesh Das; Subhasis Dan; Tapan Kumar Pal
Journal:  J Adv Pharm Technol Res       Date:  2014-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.